ArticleBMJ (Clinical research ed.)2012
Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women.
Article in BMJ (Clinical research ed.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 247 papers, 7 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
247 citing papers in PubMed, 7 syntheses or guidelines pooled it.
- Pooled it
- The Impact of Tumor Boards on Breast Cancer Care: Evidence from a Systematic Literature Review and Meta-Analysis.International journal of environmental research and public health · 2022Pooled it
- Improved Overall Survival of Colorectal Cancer under Multidisciplinary Team: A Meta-Analysis.BioMed research international · 2021Pooled it
- The requirements of a specialist breast centre.Breast (Edinburgh, Scotland) · 2020Guideline
- ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer.ESMO open · 2020Guideline
- The impact of tumor board on cancer care: evidence from an umbrella review.BMC health services research · 2020Pooled it
- The Value of Multidisciplinary Team Meetings for Patients with Gastrointestinal Malignancies: A Systematic Review.Annals of surgical oncology · 2017Pooled it
- A randomized, double-blind, phase III, non-inferiority clinical trial comparing the efficacy and safety of TA4415V (a proposed Trastuzumab biosimilar) and Herceptin (Trastuzumab reference product) in HER2-positive early-stage breast Cancer patients.BMC pharmacology & toxicology · 2022Trial
- Association of Cancer Care Quality Certification With Survival Across Multiple Cancer Types: A Population-Based Cohort Study in Taiwan.International journal of cancer · 2026Article
- Large Language Models in Multidisciplinary Decision-Making for Hepatopancreatobiliary Oncology: Retrospective Comparative Feasibility Study.Journal of medical Internet research · 2026Article
- Association of multidisciplinary team management with survival in sinonasal malignancies: a real-world IPTW cohort study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026Article
- Factors influencing discussion duration in breast cancer multidisciplinary team meetings: insights for streamlining care.Breast cancer research and treatment · 2026Article
- Breast Cancer Multi-Disciplinary Team Meetings in a Resource-Constrained System: Are Patients Receiving the Treatment Recommended?World journal of surgery · 2026Article
- Benchmarking large language models in breast cancer care: agreement with radiology-led multidisciplinary tumor board decisions.BMC medical informatics and decision making · 2026Article
- Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.Current oncology (Toronto, Ont.) · 2026Article
- Endometrial cancer mortality and its trends in China from 2004-2021.BMC cancer · 2026Article
- Quality of life following completion of surgery and chemoradiation among Sri Lankan women with breast cancer.BMC cancer · 2026Article
- Evaluating the Role of Artificial Intelligence in Enhancing Multidisciplinary Team Decisions for Breast Cancer Management.European journal of breast health · 2026Article
- Incidental pulmonary leiomyoma in a patient with invasive mucinous breast carcinoma: A diagnostic challenge.Radiology case reports · 2026Article
- A Dual-Perspective Comparison of Classical and Clinic-Based Multidisciplinary Team Models in Cancer Care: A Cross-Sectional and Qualitative Study.Health science reports · 2026Article
187 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo describe the effect of multidisciplinary care on survival in women treated for breast cancer.
designRetrospective, comparative, non-randomised, interventional cohort study.
settingNHS hospitals, health boards in the west of Scotland, UK.
participants14,358 patients diagnosed with symptomatic invasive breast cancer between 1990 and 2000, residing in health board areas in the west of Scotland. 13,722 (95.6%) patients were eligible (excluding 16 diagnoses of inflammatory cancers and 620 diagnoses of breast cancer at death).
interventionIn 1995, multidisciplinary team working was introduced in hospitals throughout one health board area (Greater Glasgow; intervention area), but not in other health board areas in the west of Scotland (non-intervention area).
main outcome measuresBreast cancer specific mortality and all cause mortality.
resultsBefore the introduction of multidisciplinary care (analysed time period January 1990 to September 1995), breast cancer mortality was 11% higher in the intervention area than in the non-intervention area (hazard ratio adjusted for year of incidence, age at diagnosis, and deprivation, 1.11; 95% confidence interval 1.00 to 1.20). After multidisciplinary care was introduced (time period October 1995 to December 2000), breast cancer mortality was 18% lower in the intervention area than in the non-intervention area (0.82, 0.74 to 0.91). All cause mortality did not differ significantly between populations in the earlier period, but was 11% lower in the intervention area than in the non-interventional area in the later period (0.89, 0.82 to 0.97). Interrupted time series analyses showed a significant improvement in breast cancer survival in the intervention area in 1996, compared with the expected survival in the same year had the pre-intervention trend continued (P=0.004). This improvement was maintained after the intervention was introduced.
conclusionIntroduction of multidisciplinary care was associated with improved survival and reduced variation in survival among hospitals. Further analysis of clinical audit data for multidisciplinary care could identify which aspects of care are most associated with survival benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.